Skip to main content

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Identificación de nuevas dianas para el tratamiento del cáncer basada en el estudio de factores cap-independientes activados en tumores malignos

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Maria Teresa Salcedo Allende, Javier Hernandez Losa, Vicente Peg Camara, Trond Aasen
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 9283
Reference: FMM-2011-11
Duration: 01/09/2011 - 31/08/2012

Identification of new molecules and mechanisms of myometrial infiltration and early diagnosis to improve survival in endometrial cancer

IP: Jaume Reventós Puigjaner
Collaborators: Maria Asuncion Perez Benavente, Eva Colas Ortega, Josep Castellví Vives
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 133100
Reference: SAF2011-26548
Duration: 01/01/2012 - 31/12/2014

Ministerio de Ciencia

Caracterización Molecular de los procesos de infiltración y diseminación tumorales y desarrollo de metástasis en cáncer de endometrio. Papel de RUNX1 en la promoción de las metástasis.

IP: Jaume Reventós Puigjaner
Collaborators: Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 96800
Reference: SAF2008-03996
Duration: 01/01/2009 - 31/12/2011

Ministerio de Ciencia

Correlación de la expresión de factores embudo 4EBP1, con la expresión de diferentes receptores epidérmicos: papel de HER3, HER2 y sus formas truncadas en diferentes tipos de tumor

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Josep Castellví Vives, Javier Hernandez Losa
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 75000
Reference: FMMA/13/2008
Duration: 30/07/2008 - 29/07/2011

Related news

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

Related professionals

Sandra Vilaró Miranda

Sandra Vilaró Miranda

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Susana González Suárez

Susana González Suárez

Postdoctoral researcher
Cardiovascular Diseases
Read more
Rafael Garcia Merida

Rafael Garcia Merida

Administration and Management
Clinical Neuroimmunology
Read more
Eugenio Andres Aliaga Martinez

Eugenio Andres Aliaga Martinez

Postdoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.